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ABSTRACT
The representation of cyclins and cyclin-dependent kinases (cdks) was
analyzed during progressive development of the bone cell phenotype in
cultures of normal diploid rat calvarÃ-a!osteoblasts. Three developmental
stages were examined: (a) proliferation; (In monolayer confluency; and
ic i mineralization of the bone extracellular matrix. We demonstrate that
the presence of cyclins and cdks is not restricted to the proliferation
period. Consistent with their role in cell cycle progression, cdc2 and cdk2
decrease postproliferatively. However, cdk4 and cyclins A, B, and Dl
persist in confluent cells. Cyclin E is significantly up-regulated during the
extracellular matrix mineralization developmental period. Examination of
the cytoplasmic levels of these cell cycle regulatory proteins indicates a
marked increase in cyclin B in the late differentiation stage. The elevation
of nuclear cyclin E and cytoplasmic cyclin B is not observed in osteoblasts
maintained under culture conditions that do not support differentiation.
Furthermore, treatment with transforming growth factor /! for 48 h
during the proliferation period renders the cells incompetent for differ
entiation and abrogates the postproliferative up-regulation of cyclins B
and E. Density-induced growth inhibition of KOS 17/2.8 osteosarcoma
cells is not accompanied by up-regulation of nuclear cyclin E and cyto
plasmic cyclin B when compared to the proliferation period. This obser
vation is consistent with abrogation of both growth control and differen
tiation regulatory mechanisms in tumor cells. These results suggest that
cell cycle regulatory proteins function not only during proliferation but
may also play a role in normal diploid osteoblast differentiation.
INTRODUCTION
Interrelationships between proliferation and differentiation are
mediated by cross talk between regulatory mechanisms controlling
the cell cycle and initiation of gene expression required for phe-
notypic properties characteristic of specialized cells and tissues.
During the past several years there have been significant advances
in our understanding of both the regulated and regulatory events
that control competency for proliferation and cell cycle progres
sion. Particularly important have been the identification and char
acterization of the proliferation-related proteins, which include the
cyclins, cdks/ and cdk inhibitors (reviewed in Refs. 1-5). As cells
progress through the cell cycle, stage-specific modifications in the
representation of cyclins occur. These cell cycle-regulated proteins
function as regulatory subunits for constitutively expressed cdks,
supporting activation of kinase activity for phosphorylation of
regulatory molecules that contribute to control of passage through
the cell cycle. In addition, cyclins and cdks participate in tran
scription factor complexes that interact with promoter elements of
cell cycle regulated genes (6, 7).
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Abbreviation of G, and acceleration of the G,-S transition by
overexpression of cyclins Dl and E directly implicate cyclins in
cell cycle control (8-11). Other examples of functional involve
ment for cyclins in cell cycle regulation are provided by induction
of the G2-M transition when the cyclin B-cdc2 complex was
microinjected into oocytes (12). Consistent with primary roles for
cyclins in cell cycle control, aberrations in cellular levels of
cyclins, particularly cyclins DI, D2, and E, have been observed in
transformed and tumor cells where growth-regulatory mechanisms
have been compromised (4).
Several lines of evidence implicate the cyclin-related proteins in
control of competency for differentiation. Down-regulation of cell
cycle-regulatory genes has been observed after induction of differen
tiation. HL60 promyelocytic leukemia cells exhibit decreased mRNA
levels for the G,-related proteins cyclin Bl, cdc2, and cdc25 after
phorbol ester induction of differentiation along the monocyte/macro-
phage lineage (13). Permissiveness for hexamethylene bisacetamide
induction of differentiation in murine erythroleukemia cells is depend
ent on reduced expression of the G,-related kinase cdk4 (14). Differ
entiation of 32D myeloid cells by granulocyte colony-stimulating
factor is blocked by overexpression of the G, D2 or D3 but not Dl
(15). Cyclin Dl impedes lymphocyte maturation in transgenic mice
(16), and ectopie expression of cyclin Dl inhibits C2C12 myoblast
differentiation in a dose-dependent manner (17).
Taken together, these and other studies are consistent with a dual
role for cyclin-related proteins in supporting cell cycle progression in
proliferating cells while preventing expression of genes associated
with postproliferative phenotypic properties of differentiated cells.
Evidence for involvement of cyclin-related proteins in control of
differentiation is further provided by the selective expression of cdk5
in terminally differentiated neurons (18). These findings implicate
cyclin-related proteins in control of gene expression required for
initiation and maintenance of phenotypic properties characteristic of
specialized cells and tissues.
Osteoblast differentiation is a multistep developmental process
initially involving expression of cell growth and cell cycle regulatory
genes to support proliferation and genes associated with extracellular
matrix biosynthesis (reviewed in Ref. 19). Then, postproliferatively,
there is a sequential expression of genes required for the organization
and mineralization of a bone extracellular matrix. Down-regulation of
proliferation at a key developmental transition point is necessary for
transcription of genes functionally related to expression of the mature
osteoblast phenotype. In contrast to the sequential and mutually ex
clusive expression of cell growth and tissue-specific genes in normal
diploid osteoblasts, osteosarcoma cells coexpress genes involved with
growth control and regulation of bone phenotypic genes (20).
In this paper we report modifications in both the representation and
subcellular distribution of cell cycle regulatory proteins during se
quential stages of osteoblast differentiation. Increased nuclear levels
of cyclin E and cytoplasmic levels of cyclin B are observed postpro
liferatively during differentiation of normal diploid osteoblasts. These
alterations do not occur during growth arrest, which is uncoupled from
expression of skeletal phenotypic genes, or in osteosarcoma cells.
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Fig. 1. Cultures of normal diploid rat calvarial osteoblasts were maintained under conditions that support differentiation, as described in "Materials and Methods." A, three
developmental stages [proliferation (left; X 250); monolayer confluency (middle; X 250); and differentiation (riffln; X 75)] are shown by light microscopy. Note the postconfluent
nodule formation in the differentiation stage, where mineralization of the extracellular matrix occurs. B, mRNA was isolated at the three developmental stages shown in A, and Northern
analysis was performed with 15 /ig of RNA. Blots were probed with either a (listone H4 cDNA as a marker for proliferation or alkaline phosphatase (AP) and OC cDNAs as
differentiation markers. P, proliferation; C, confluency; D, differentiation.
MATERIALS AND METHODS
Cell Culture. Primary osteoblasts were isolated from fetal rat calvariae and
maintained in MEM supplemented with 10% PCS (21). Ascorbic acid (50
fig/ml) and ÃŸ-glycerophosphate (10 mM) supplementation of the medium was
initiated at confluence. For secondary cultures, cells were trypsinized before
reaching confluency (day 5) and replated at a density of 9 x IO5 cells/100-mm
plate. Unless otherwise stated, secondary cultures were fed as above. The first
two feedings contained 10~7 M dexamethasone to enhance expression of the
bone cell phenotype. At principal developmental stages, cells were harvested
for protein and RNA isolation. To obtain nondifferentiating osteoblasts, sec
ondary cultures were maintained in MEM supplemented with 10% PCS but
with no additions of dexamethasone, ascorbic acid, and ÃŸ-glycerophosphate.
For TGF-ÃŸtreatment, 100 pM TGF-ÃŸwas added lo primary cultures during the
proliferation period for 48 h. The cultures were returned to differentiation
medium and collected at later times with untreated controls. Rat osteosarcoma
cells (ROS 17/2.8; Merck, Sharp and Dohme, West Point, PA) were grown in
F-12 medium supplemented with 5% horse serum. Cells (passages 16-18)
were plated at a density of 7 X lO'/lOO-mm dish. At three different time points
(proliferation, confluence, and a late time point of density-induced growth
inhibition), cells were harvested for protein and RNA isolation. Medium from
all cultures was collected for OC analysis by RIA (22). Unless otherwise
stated, all cell samples for protein and mRNA analyses were collected 24 h
after medium change.
Western Analysis. Cells were scraped in ice-cold PBS, centrifuged, and
resuspended in ice-cold 1% citric acid for cell fractionation as described by
Bailly et al. (23). Briefly, the resuspended cells were homogenized (35
strokes) in a tight fitting Dounce homogenizer, sedimented at 300 X g, and
washed once in 0.1% citric acid and then in a 10 mM Tris-HCI buffer (pH
7.4) containing 5 mM MgCl,. The citric acid-extracted cytoplasmic proteins
were precipitated in 90% methanol (overnight at â€”¿20Â°c).The nuclear and
cytoplasmic fractions were solubilized in a 60 mM Tris-HCI buffer (pH 6.8)
containing 2% SDS. Before each Western analysis, protein concentration
was determined (Pierce Micro BCA Protein Assay kit 23235), and equiv
alent amounts were subjected to SDS PAGE (12%) in the absence of
reducing agents, followed by electroblotting to nitrocellulose membrane
(Hoefer Scientific Instrument, CA). Immunodetection was performed with
the enhanced chemiluminescence kit (Amersham). Antibodies to cdc2,
cdk2, and cdk4, and cyclins B l, D1, and E (sc-54, se-163, sc-260, sc-245,
sc-246, and sc-247, respectively) were from Santa Cruz Biotechnology,
Inc., Santa Cruz, CA. Rabbit polyclonal antibodies to human cyclins A and
Fig. 2. ,4, normal diploid osteoblasts shown in
Fig. \A were harvested 24 h after medium change,
at the three developmental stages, followed by iso
lation of the nuclear (Nue) and cytoplasmic (Cvr)
fractions. Twenty fig Â°feither nuclear proteins or
the melhanol precipitate of the cytoplasmic frac
tions were subjected to Western analysis using an
tibodies to the kinases cdc2. cdk2. and cdk4, and the
cyclins (rvr) A, B. Dl, and E. P, proliferation; C,
confluency; D. differentiation. B. cells as in A were
harvested at the indicated time points after feeding;
analyses of representative proteins are shown.
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Fig. 3. Normal diploid osleoblasts isolated as in Figs, l and 2 were maintained under
nondifferentiating culture conditions as described in "Materials and Methods." A. samples
of 24-h conditioned medium were collected during proliferation (P), at confluency (C),
and at a late postconfluent stage (/V; nondifferentiated) for OC RIA. The OC level
measured in 24-h conditioned medium of differentiating osleoblasts (D) maintained as in
Fig. 1 is also shown. Columns, mean values from 3 independent determinations; bara, SD.
The OC level in differentiated cultures is defined as 100%. B, Western analysis is shown
for cytoplasmic cyclin B (CvÃ-cycB). and nuclear (Nuc) cyclin E and cdc2. Results from
differentiated ostcoblasts (D) are shown for comparison.
Bl were prepared in the laboratory of Dr. R. Schlegel. Results of the
Western analysis were reproduced in at least 3 independent osteoblast
differentiation courses.
Northern Analysis. Cells were scraped in guanidinium solution (24),
and RNA was analyzed as described (25). Samples were electrophoresed in
1% agarose gels and blotted overnight onto nylon membrane (Zelaprobe
Blotting Membrane, Bio-Rad). Prehybridization (12 h at 42Â°C)and hybrid
ization (overnight at 42Â°C)were performed in 50% formamide-4.7X SSPE
[IX SSPE is 0.18 MNaCl-10 mM NaH2PO4 (pH 7.4)-l mM EDTA], 0.5%
SDS, 5x Denhardt's solution (Ix Denhardt's solution = 0.2(w/v) each of
Ficoll, polyvinylpyrolidone, and BSA), and 200 fig/ml salmon-sperm
DNA. Membranes were washed in a 2x SSC solution (IX SSC is 0.15 M
NaCl-15 mM sodium citrate) containing 0.1% SDS at 50Â°Cfor 25 min,
followed by a more stringent wash (IX SSC-0.1% SDS) when necessary.
cDNAs for histone H4 (26), alkaline phosphatase (27), and OC (28) were
used.
RESULTS AND DISCUSSION
Nuclear Cyclin E and Cytoplasmic Cyclin B Are Elevated in
Postproliferative Differentiating Osteoblasts. To address involve
ment of cell cycle regulatory proteins in osteohlast differentiation, we
determined the nuclear and cytoplasmic representation of 4 cyclins
and 3 cdks in cultured rat calvarial osteoblasts during 3 developmental
periods (proliferation, monolayer confluency, and extracellular matrix
mineralization). Fig. IA presents micrographs of cells in these three
developmental periods. Fig. \B shows Northern analysis of histone,
alkaline phosphatase, and OC gene transcripts during osteoblast dif
ferentiation, indicating that there is a reciprocal relationship between
proliferation and postproliferative expression of bone cell phenotypic
properties. The high levels of OC expression in postproliferative
mature osteoblasts provide evidence for differentiation of the osteo
blast cultures (see Fig. 1 and Ref. 19).
Western analysis of cyclins and cdks is shown in Fig. 2. The
nuclear levels of cdc2 and cdk2 kinases decline postproliferatively. A
parallel relationship is therefore observed between proliferation and
expression of two kinases that are primary mediators of cell cycle
progression. However, low but detectable levels of these kinases are
present throughout the osteoblast developmental sequence including
in differentiated osteoblasts. Nuclear levels of cdk4 exhibit a modest
increase at confluency. In postproliferative differentiated cells, cdk4
declines to levels below those observed during active proliferation.
Significant nuclear levels of cyclins A, B, Dl, and E are retained in
differentiated osteoblasts. Particularly striking is the increase in nu
clear abundance of cyclin E in the differentiated osteoblasts (Fig. 2A).
The multiple cyclin E-immunoreactive bands (Figs. 2 and 4fl) may
represent products of cyclin E-related genes or alternative splicing of
cyclin E mRNA (10, 29).
Fig. 2A also shows cytoplasmic levels of cell cycle regulatory
factors during the osteoblast developmental sequence. As observed in
the nuclear fractions, both cdc2 and cdk2 but not cdk4 are signifi
cantly reduced in differentiating cells. A dramatic increase is observed
in cytoplasmic cyclin B during differentiation. This increase was
documented in three independent experiments using two different
cyclin B antibodies. The findings confirm the correlation between
cyclin B expression and the extent of osteoblast differentiation. It is
noteworthy that the increase in cyclin E observed in differentiated
cells is specific to the nuclear fraction, whereas cytoplasmic cyclin E
is reduced. Taken together, these results indicate that in contrast to the
well documented role for cyclins and cdks in governing proliferation,
nuclear cyclin E and cytoplasmic cyclin B are up-regulated during
osteoblast differentiation. Whereas Fig. 2A presents data from sam
ples harvested 24 h after medium change, Fig. 2B demonstrates
similar increase in cytoplasmic cyclin B and nuclear cyclin E in
differentiating osteoblasts in samples collected 8 and 16 h after
feeding. The expression patterns of cytoplasmic cdc2 and nuclear
cdk4 analyzed using the same blots (Fig. 2B), as well as those of all
the other components shown in Fig. 2A, were also essentially unaf
fected by the time period between feeding and collection (not shown).
Thus, the developmental changes in cellular levels of cyclin-related
proteins are independent of the serum response that occurs as a result
of medium changes during the developmental time course in cultured
osteoblasts.
Postproliferative Elevation of Cyclins B and E in Osteoblasts Is
Dependent on Differentiation. To address further the involvement
of cell cycle-regulatory factors in osteoblast differentiation, we ex
amined cyclins and cdks in osteoblast cultures under conditions that
do not support differentiation. It was necessary to establish that
changes observed in cellular levels of cyclin-related proteins in dif
ferentiating osteoblasts do not reflect a prolonged postproliferative
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Fig. 4. Primary cultures of ral calvarÃ-a!osteohlasts were maintained under differentiation conditions as described in "Materials and Methods." At the proliferating stage, one-half
of the plates were treated for 48 h with 100 p\i TGF-ÃŸto inhibit differentiation. A, 24-h accumulation of OC in the medium was determined by RIA of the proliferating (P).
differentiating (/)). and TGF-ÃŸ-treated (T) cells. Columns, mean values from 3 independent determinations; bars, SD. The values from differentiated cells are defined as 100%. B,
Western analysis was performed as described in Fig. 2 for cytoplasmic cyclin B and cdc2, as well as nuclear cyclins A, Dl, and E, and the kinases cdc2 and cdk2.
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Fig. 5. ROS 17/2.8 osteosarcoma cells were maintained as described in "Materials and Methods" and harvested when actively proliferating (P), at confluency (C). and after
density-mediated growth inhibition (/). A, 24-h OC accumulation in the culture medium was determined at the three stages by RIA. B, Northern analysis of histone H4 mRNA was
performed as in Fig. M. C, cyclins B (evi-fi) and E (rycE), exhibiting specific developmental regulation in normal diploid osteoblasts (Fig. 2), were analyzed in the nuclear and
cyloplasmic fractions of ROS 17/2.8 cells. Cyclin B of normal diploid differentiated osteoblasts (D) was analyzed as a reagent control. D, Western analysis of ROS 17/2.8 nuclear cyclin
A, cdc2, and cdk2, showing a pattern similar to that observed in normal diploid cells.
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period. Osteoblasts were isolated and cultured under conditions that
preclude differentiation as described in "Materials and Methods"
(absence of dexamethasone, ascorbic acid, and ÃŸ-glycerophosphate).
Fig. 3A indicates that under culture conditions that support prolifer
ation and subsequent growth arrest but not expression of mature
osteoblast phenotypic properties, the expression of OC, a late devel
opmental marker, is completely blocked. As shown in Fig. 3ÃŸ,nuclear
cyclin E and cytoplasmic cyclin B are not elevated in the nondiffer-
entiating cells, further indicating linkage of these two cyclins (Fig. 2)
with osteoblast differentiation. Data for differentiating osteoblasts are
shown for comparison. The patterns of appearance of cdc2 (Fig. 3),
cdk2, cdk4, and cyclins A and Dl (not shown) in nondifferentiating
cells were generally similar to those of differentiating cells.
TGF-ÃŸImpedes Osteoblast Differentiation and Up-Regulation
of Cytoplasmic Cyclin B and Nuclear Cyclin E. TGF-ÃŸinhibits
osteoblast differentiation in vitro (30-32). TGF-ÃŸtreatment during
osteoblast proliferation results in loss of competency for differentia
tion at later postconfluent stages. If changes in nuclear cyclin E and
cytoplasmic cyclin B are functionally linked to osteoblast differenti
ation, decreased levels can be anticipated in cells treated with TGF-ÃŸ.
Primary cultures of rat calvarial derived osteoblasts exposed to TGF-ÃŸ
during the period of active growth exhibited a block in differentiation,
as indicated by reduced bone nodule formation (not shown) and OC
biosynthesis (Fig. 4A). The inhibitory effect of TGF-ÃŸis associated
with abrogation of the high levels of nuclear cyclin E and cytoplasmic
cyclin B, which is related to osteoblast differentiation as shown in Fig.
4B. Down-regulation of cytoplasmic cdc2 and nuclear cdk2 is also
prevented by TGF-ÃŸinhibition of differentiation. Nuclear levels of
cyclin A, cyclin Dl, and cdc2 were not altered in the TGFÃŸ-treated
cells as compared to differentiated cells.
Growth Inhibition of ROS 17/2.8 Osteosarcoma Cells Is Not
Accompanied by High Levels of Cytoplasmic Cyclin B or Nuclear
Cyclin E. ROS 17/2.8 osteosarcoma cells exhibit increased levels of
OC and reduced levels of histone H4 mRNA when growth inhibited
at high density (Fig. 5, A and B). However, the elevated OC levels are
not accompanied by the nodule formation or matrix mineralization
characteristic of differentiated normal rat diploid osteoblasts. The
growth-inhibited cells do not exhibit an increase in cytoplasmic cyclin
B (Fig. 5C, compare Lanes I and D), indicating the specificity of
up-regulation observed in association with cessation of proliferation
during differentiation in normal diploid cells. When compared to
confluent cells, the growth-inhibited osteosarcoma cells exhibit higher
levels of nuclear cyclin E. In contrast to the pronounced increase in
nuclear cyclin E during differentiation of normal diploid osteoblasts,
cyclin E levels are similar during proliferation and growth inhibition.
Similar patterns of cyclin A, cdc2, and cdk2 expression are observed
in osteosarcoma cells and normal diploid osteoblasts in relation to the
extent of proliferative activity (compare Fig. 5D to Fig. 2). Hence,
up-regulation of cytoplasmic cyclin B and nuclear cyclin E is asso
ciated with the expression of postproliferative differentiation markers
(OC) when coupled to the developmental process (nodule formation)
that occurs in normal diploid osteoblast differentiation.
Conclusions. During osteoblast differentiation, two cyclins (B and
E) are up-regulated postproliferatively when expression of tissue-
specific phenotypic properties are established. This activity comple
ments the well documented expression of these cyclins in proliferating
cells (1-5). Validation of the biological relevance of this observation
is provided by the absence of cyclin B and cyclin E up-regulation
when growth inhibition is not accompanied by differentiation under
multiple independent conditions.
Although it has been well documented that cyclins regulate phos-
phorylation of proteins functionally involved with growth control,
contributions to differentiation remain to be defined. During differ
entiation, cyclins and cdks may function by phosphorylation of sub
strates either similar to or distinct from those that play a role in cell
cycle regulation. Particularly important will be identification of the
catalytic subunits with which cyclins B and E interact during osteo
blast differentiation. These may be known or novel cdks (33-35).
Alterations in the representation of cdk inhibitors (36, 37) may also be
important to channel kinase activities in postproliferative osteoblasts
to differentiation-related processes. The cascade of regulatory events
that accompany and arc functionally related to late stages of postpro
liferative osteoblast differentiation are unquestionably accompanied
by and functionally coupled with phosphorylation-dependent regula
tory mechanisms. Potential involvement of cyclins that exhibit in
creased representation in mature osteoblasts in control of bone cell
structure and function is being addressed experimentally.
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